Abstract:BACKGROUND: Every existing prosthetic valve, either mechanical valve prosthesis or biovalve, has its inherent defects that are determined by its material itself and can not be avoided no matter what manufacturing technique is used. Fortunately, the concept of tissue engineering heart valve (TEHV) provides a new direction for the solution of the above-mentioned dilemma. OBJECTIVE: To analyze which kind of cells is the more suitable seeding cells for tissue engineering heart valves, well-differentiated vascular endothelial cells or bone marrow mesenchymal stem cells (MSCs), by comparing the obtaining methods of the two, as well as their in vitro proliferation abilities and their growth potentials on acellular matrixes. DESIGN, TIME AND SETTING: A single sample observation was completed in the Animal Experiment Base of Shanghai Chest Hospital from June to September in 2008. MATERIALS: Acellular matrixes were obtained by digesting aortic valves of pigs with Trypsin-EDTA, Triton X-100, DNase and RNase. Seeding cells were obtained from the great saphenous veins, the lateral femoral arteries and the ribs marrows of a male hybrid dog of two years old, weighing 12 kg. METHODS: Trypsin digestion was adopted to collect endothelial cells which, together with the bone marrow cells, were cultured separately. The endothelial cells and MSCs were harvested with adherence method. Then, the MSCs were induced into endothelial cells using endothelial cell growth factors, and the cell growth curve was drawn simultaneously. After that, MSCs were stained with the anti-VIII factor antibody and the anti-vascular endothelial growth factor (anti-VEGF) antibody, and then were observed under the fluorescence microscope. After 3 days of culture on acellular valves, seeding cells were observed under the scanning electron microscope. MAIN OUTCOME MEASURES: Circled digit oneThe wound healing of the experiment dog; Circled digit twoThe culture and proliferation of cells; Circled digit threeThe phenotype analyses and morphology observation of MSCs. RESULTS: Compared with well-differentiated vascular endothelial cells, MSCs showed a much greater expanding ability in vitro. The doubling time of MSCs was 30 hours according to the cell growth curve, which is a well contrast to the flat one of the mature endothelial cells. Moreover, MSCs showed positive fluorescence staining after being stained with fluorescent anti-factor VBl antibody and fluorescent anti-VEGF antibody. Under scanning electron microscope, adherent stellate cells could be seen scattering on the culturing acellular valves of MSCs. CONCLUSION: MSCs not only have a strong ability of in vitro proliferation, but also can be induced into endothelial cells by endothelial cell growth factors. What's more, they can grow on and adhere to acellular valves. All of these show that MSCs are the ideal seeding cells for TEHV preparation.

Construction of Tissue Engineered Heart Valves Based on Decellularized Bovine Pericardium

In Vitro Construction of Tissue-Engineered Heart Valves with Endothelial Cells Differentiated from Bone Marrow Mesenchymal Stem Cells

Experimental Study of Tissue Engineered Heart Valves Implanted in Nude Mice

Study of Decellularization of Bovine Pericardium Tissue Engineered Heart Valves Scaffold

Tissue Engineering of Heart Valves: Endothelial Cells Differentiated from Endothelial Progenitor Cells Seeding of Acellularized Porcine Valves

[Research on Application of Modified Polyethylene Glycol Hydrogels in the Construction of Tissue Engineered Heart Valve].

Primary co-culture of mixed vascular cells for tissue engineered heart valves

Surface Biofunctionalization of the Decellularized Porcine Aortic Valve with VEGF-loaded Nanoparticles for Accelerating Endothelialization

Application of endothelial cells cultured from human bone marrow stromal cells in tissue-engineered heart valve

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

Ideal seeding cells for tissue engineering heart valves

Immune Properties of Decellular Human Tissue-Engineering Aortic Valves Conduits

Large-Scale Surface Modification of Decellularized Matrix with Erythrocyte Membrane for Promoting in Situ Regeneration of Heart Valve

Comparison of Decellularizative Procedures of Bovine Pericardium Tissue-Engineering Heart Valve Scaffold

In Vitro Experience with Tissue-Engineered Heart Valve Leaflets

Experimental research on tissue engineering for cellular reconstitution on pericardial fibrous scaffold in vitro

Application of Decellularized Scaffold Combined with Loaded Nanoparticles for Heart Valve Tissue Engineering in Vitro.

Re-endothelialization of Decellularized Scaffolds with Endothelial Progenitor Cell Capturing Aptamer: A New Strategy for Tissue-Engineered Heart Valve

Promotion of Adhesion and Proliferation of Endothelial Progenitor Cells on Decellularized Valves by Covalent Incorporation of RGD Peptide and VEGF.

Strengthened Decellularized Porcine Valves Via Polyvinyl Alcohol As a Template Improving Processability

Decellularized Xenogenic Valve Scaffolds Coated with Biodegradable Polymer for Heart Valve Tissue Engineering